Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Sekiguchi; Yoshinori
Address:
Tokyo, JP
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8030499 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocy October 4, 2011
It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effect on depression, anxiety, Alzheimer's disease,
7601734 Cyclic amine compound October 13, 2009
An object of the present invention is to provide a cyclic amine compound which has a potent inhibitory effect on the binding of .alpha.2C-adrenoceptor and is useful in preventing and treating disorders attributable to .alpha.2C-adrenoceptor.The above-described object is solved by the
7544690 MCH receptor antagonists June 9, 2009
The present invention relates to novel compounds of the formula (I) which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of obesity, obesity related disorders, anxiety, or depression.
7528124 1,3-dihydro-2H-indol-2-one derivative May 5, 2009
A 1,3-dihydro-2H-indol-2-one derivative expressed by Formula 1 (wherein R.sub.1 is a halogen atom, a C.sub.1 to C.sub.4 alkyl group, etc., and R.sub.2 is a hydrogen atom, a halogen atom, etc., or R.sub.2 is in the 6-position of the indol-2-one and R.sub.1 and R.sub.2 join together to
5952715 Chip type electronic part September 14, 1999
A chip type electronic part of the present invention includes tapered notches rising from the bottom of the body of a molding. With this configuration, the electronic part achieves a high volume efficiency and a great bonding strength to a circuit board after soldering.
5597921 Indolo[2,3-b]quinoxaline derivatives January 28, 1997
Indolo[2,3-b]quinoxaline derivatives represented by the following formula: ##STR1## wherein one of R.sup.1 and R.sup.2 is a hydrogen atom and the other is a group of the formula:etc, and R.sup.3 is a hydrogen atom, a methyl group, etc.; and pharmaceutically acceptable salts thereof h
5576927 Electrolytic chip capacitor November 19, 1996
A solid electrolytic chip capacitor in which L-shaped portions of the anode terminal and cathode terminal form slanting surfaces which project beyond the projecting side surfaces of the resin sheathing.
5495046 Alkoxyphenylalkylamine derivatives February 27, 1996
An alkoxyphenylalkylamine derivative represented by the following formula: ##STR1## (wherein X.sup.1 and X.sup.2 may be either the same or different from each other and each represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an










 
 
  Recently Added Patents
Method for parking or exiting a parking bay and for avoiding a collision of a vehicle, and corresponding assistance systems and vehicle
Base station, relay station, and bandwidth allocation method
Pharmaceutical powder compositions
Light-emitting device with a spacer at bottom surface
Graphical communication user interface with graphical position user input mechanism for selecting a display image
Headphone
Hydrating lounge chair
  Randomly Featured Patents
Liquid crystal display wide viewing angle polarizing film and liquid crystal display wide viewing angle polarizing adhesive film
Large scale simulation architecture for distributed networking waveforms
Optical correlation velocity log
Method of fabricating semiconductor device and semiconductor device fabricated thereby
Pulse transmitters having multiple outputs in phase relationship and methods of operation
Retraction locking safety belt retractor
Focal-plane shutter and image pickup apparatus
Sheet-like preparation
Formaldehyde free binders
Methods of treatment comprising administration of Substance P